BOSTON SCIENTIFIC CORP 10-Q filing
Filed 2026-05-01 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0000885725-26-000033
- Form type
- 10-Q
- CIK
- 0000885725
- Primary document
- https://www.sec.gov/Archives/edgar/data/885725/000088572526000033/bsx-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for BOSTON SCIENTIFIC CORP.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $5.2B | - | - |
| Cost Of Revenue | $1.6B | - | - |
| Gross Profit | $3.6B | - | - |
| Operating Income | $1.1B | - | - |
| Eps Basic | 0.9 | - | - |
| Eps Diluted | 0.9 | - | - |
| Cash And Equivalents | $1.5B | - | - |
| Total Assets | $44.4B | - | - |
| Shareholders Equity | $25.9B | - | - |
| Operating Cash Flow | $348.0M | - | - |
| Capital Expenditures | $177.0M | - | - |